Avital Pushett

Head of ALS Clinical Program

Leader of the ALS clinical program at NeuroSense Therapeutics.

Avital is an experienced researcher, focusing on stem cells and their development and maintenance.

She is a certified CRA, and holds a drug development and regulatory compliance certificate from Bio Medical Research Design Ltd. She also received an excellence award for her Master’s thesis.

Avital is extremely devoted to the cause, since losing her father to ALS.

MSc in Biomedical Sciences, from The Hebrew University